Advertisement
Advertisement

RLAY

RLAY logo

Relay Therapeutics, Inc. Common Stock

19.74
USD
Sponsored
+0.84
+4.44%
Jul 07, 16:00 UTC -4
Closed
exchange

After-Market

20.02

+0.29
+1.44%

RLAY Earnings Reports

Positive Surprise Ratio

RLAY beat 14 of 24 last estimates.

58%

Next Report

Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
$673.20K
/
-$0.40
Implied change from Q1 26 (Revenue/ EPS)
-77.56%
/
-2.44%
Implied change from Q2 25 (Revenue/ EPS)
-0.56%
/
-2.44%

Relay Therapeutics, Inc. Common Stock earnings per share and revenue

On May 05, 2026, RLAY reported earnings of -0.41 USD per share (EPS) for Q1 26, missing the estimate of -0.38 USD, resulting in a -6.66% surprise. Revenue reached 3.00 million, compared to an expected 2.61 million, with a 14.89% difference. The market reacted with a -0.62% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -0.40 USD, with revenue projected to reach 673.20 thousand USD, implying an decrease of -2.44% EPS, and decrease of -77.56% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Cybin Inc. Common Stock
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.91
Actual
-$1.16
Surprise
-27.08%
FAQ
For Q1 2026, Relay Therapeutics, Inc. Common Stock reported EPS of -$0.41, missing estimates by -6.66%, and revenue of $3.00M, 14.89% above expectations.
The stock price moved down -0.62%, changed from $13.00 before the earnings release to $12.92 the day after.
The next earning report is scheduled for Aug 06, 2026.
Based on 9 analysts, Relay Therapeutics, Inc. Common Stock is expected to report EPS of -$0.40 and revenue of $673.20K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement